Effectiveness and safety of using Podikon digital silicone padding in the primary prevention of neuropathic lesions in the forefoot of diabetic patients.
BACKGROUND
In diabetic patients with complications from peripheral neuropathy, the hyperpressure areas can rapidly lead to ulcerative lesions in the absence of protective sensation. Partial digital silicone orthoses could provide an innovative and functional therapeutic solution in the management of preulcerative areas of the forefoot in neuropathic diabetic patients. We clinically tested this hypothesis.


METHODS
Digital off-loading silicone padding was prepared for 89 neuropathic patients with deformities and localized hyperkeratosis in the forefoot. After 3 months and in basal conditions, the number of areas of hyperkeratosis was evaluated together with the hardness of the skin, the number of active lesions, and any adverse events associated with use of the orthosis. The patients were compared to a control group of 78 randomized patients undergoing standard therapy. In a subgroup of 10 patients, a static and dynamic biomechanical evaluation was also conducted with a computerized podobarometric platform.


RESULTS
Both the number of lesions and the prevalence of hyperkeratosis and skin hardness were significantly lower (P < .01) in the group treated with the silicone orthoses than in the control group. No adverse events were reported during the 3 months of observation. The podobarometric analysis highlighted a significant (P < .001) reduction of peak pressure in the areas undergoing orthotic correction.


CONCLUSIONS
Silicone padding is effective and safe in the prevention of lesions in neuropathic patients at high risk of ulceration and significantly reduces the incidence of new lesions in the 3-month follow-up period compared to standard treatment.
Scirè
Vincenzo
V
Department of Endocrinology and Metabolism, University of Pisa, Pisa, Italy.
Leporati
Elisa
E
Teobaldi
Ilaria
I
Nobili
Laura Ambrosini
LA
Rizzo
Loredana
L
Piaggesi
Alberto
A
D000368:Aged; D017719:Diabetic Foot; D003929:Diabetic Neuropathies / Q000517:prevention & control*; D004869:Equipment Safety; D005545:Forefoot, Human; D006801:Humans; D008875:Middle Aged; D009989:Orthotic Devices / Q000592:standards; D012828:Silicones
D012828:Silicones